Tuesday, June 27, 2017

FDA Approves Daratumumab in Combination With Pomalidomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

This is my current mix...


http://www.ascopost.com/News/57747

No comments:

Post a Comment

MMRF Updates on COVID19

The MMRF has free weekly webinars on the impacts of COVID-19 on myeloma patients. Register here.